Managing Burnout in the Pharmacy
Pharmacy Times
SEPTEMBER 25, 2023
Physical symptoms of burnout can include headaches, digestive problems, sleep disturbances, and increased susceptibility to illnesses due to a weakened immune system.
September, 2023
167 
CVS Pharmacists, Staff in Kansas City Stage Walkout Over Working Conditions
Drug Topics
SEPTEMBER 26, 2023
Pharmacists at nearly 2 dozen CVS pharmacy locations called out sick Thursday and Friday to protest recent corporate decisions they say put patients at risk of serious harm.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Pharmacies and Labs Must Work Together to Accelerate Test and Treat Opportunities, Enhance Patient Care Equity, Improve Health Outcomes
Pharmacy Times
SEPTEMBER 27, 2023
Working together, pharmacies and labs can answer the call to align and back legislation that supports pharmacists as providers, help patients gain greater access to affordable care, and reap the benefits of improved health outcomes while growing business revenue.
WHO recommends dropping component of many flu vaccines
STAT
SEPTEMBER 29, 2023
The World Health Organization has recommended dropping a component of many flu vaccines because the viruses it protects against appear to have been driven into extinction in the Covid-19 pandemic. A family of viruses known as influenza B/Yamagata has not been seen since March 2020, when flu circulation worldwide declined to very low levels in the face of the onslaught of Covid and the protections people took to avoid contracting it.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
FTC sues PE-backed anesthesia provider for monopolistic roll-ups, price setting
Fierce Healthcare
SEPTEMBER 21, 2023
Federal regulators have accused a major Texas-based anesthesia provider and its parent private equity firm of a decade-long, three-pronged scheme to suppress competition and drive-up prices. | U.S. Anesthesia Partners and Welsh, Carson, Anderson & Stowe, its private equity backer, have "cost Texans tens of millions of dollars more each year" by suppressing competition over the course of a decade, the regulator alleges.
Pfizer, Moderna score FDA nods for next round of seasonal COVID-19 vaccines
Fierce Pharma
SEPTEMBER 11, 2023
Out with the old and in with the new: Monday, the U.S. | The FDA has approved Pfizer and Moderna’s separate vaccine formulations that target current variants of the disease. Each company’s shot is approved for people ages 12 and up and emergency authorized for patients 6 months old to 11 years old.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Breaking: Class Action Lawsuit Filed Against CVS Health, Caremark, Aetna to Recoup DIR Fees
Drug Topics
SEPTEMBER 27, 2023
The class action lawsuit against CVS Health, Caremark, and Aetna was announced earlier today.
Technology Tools Increase Patient Safety in the Pharmacy
Drug Topics
SEPTEMBER 18, 2023
From automated medication dispensing systems to telepharmacy services, technology can help reduce the risk of adverse patient events.
Pharmacy Organizations Establish Pharmacy Workforce Suicide Awareness Day
Drug Topics
SEPTEMBER 20, 2023
Suicides among health care professionals are estimated to occur at a higher rate than in the general public.
COVID-19 ICU Admissions, Deaths Associated With Old Age and Multimorbidity
Drug Topics
SEPTEMBER 19, 2023
The presence of 4 or more comorbidities was strongly associated with a higher risk of critical outcomes, regardless of vaccination status.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
FDA Grants Tentative Approval to Generic Triumpeq PD for Children With HIV
Drug Topics
SEPTEMBER 14, 2023
Abacavir/dolutegravir/lamivudine is a fixed-dose combination containing two nucleoside reverse transcriptase inhibitors (NRTIs) and integrase strand transfer inhibitor (INSTI).
Education Gaps Exist for Veterinary Pharmacy
Drug Topics
SEPTEMBER 22, 2023
Limited veterinary pharmacy training is available, other than a handful of pharmacy schools that provide elective courses on the topic.
Breaking: FDA Approves, Authorizes Updated Monovalent COVID-19 Vaccines
Drug Topics
SEPTEMBER 11, 2023
Bivalent COVID-19 vaccines by both Moderna and Pfizer-BioNTech are no longer authorized for use in the United States.
CVS Implements Measures to Improve Working Conditions After More Kansas City Pharmacists Stage Walkouts
Drug Topics
SEPTEMBER 29, 2023
After several walkouts protesting poor working conditions, company executives and protest organizers came to an agreement that includes more hours for technicians and vaccinations being reduced to a manageable volume.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Glycemic Control in Patients With Type 1 Diabetes Worse Around Holidays, Winter Months
Drug Topics
SEPTEMBER 28, 2023
A new study from Dartmouth College found that patients maintained healthier blood sugar levels from April to September.
Independent Pharmacies Say They Can Help Patients Impacted by Chain Store Closures, NCPA Survey Finds
Drug Topics
SEPTEMBER 29, 2023
A new poll from the organization surveyed 10000 independent community pharmacy owners on current worries in the industry and how they are being impacted by the ongoing national drug shortage.
Could Higher Doses of Buprenorphine Help People With OUD Stay in Treatment?
Drug Topics
SEPTEMBER 22, 2023
Treatment with buprenorphine has more than doubled since 2009, but dosing guidelines are based on studies with people using heroin that were done before the fentanyl crisis.
TikTok Videos With Misinformation About Cancer Might be Hurting Women’s Health
Drug Topics
SEPTEMBER 21, 2023
A new study from Ohio State University found that the majority of TikTok content with information about gynecologic cancer was false or inaccurate.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
FDA Approves Empagliflozin for Use in CKD
Drug Topics
SEPTEMBER 22, 2023
This is the fourth approval for the drug, stemming from the EMPOWER clinical trial program.
OTC Products, Oral Prescriptions Demonstrate Efficacy in Episodic Migraine
Drug Topics
SEPTEMBER 19, 2023
Although there were some differences in response after dosing, both OTC and oral prescriptions demonstrated statistically significant improvements in pain.
Mobile Apps for Medication Management
Drug Topics
SEPTEMBER 19, 2023
Pharmacists and patients can utilize mobile apps to help manage medications.
2023-2024 Flu Season: What to Expect
Drug Topics
SEPTEMBER 30, 2023
As the Southern Hemisphere sees a mixed flu season, uncertainty looms for those in the North.
More Women Are Using Cannabis to Manage Menopause Symptoms
Drug Topics
SEPTEMBER 28, 2023
A new study found that the most common symptoms that cannabis was used to treat were chronic pain, anxiety, sleep problems, and stress.
Baltimore Pharmacy Owners Driven by Helping Patients with Health Barriers
Drug Topics
SEPTEMBER 21, 2023
Pharmacy owner Thuy Cao helped a patient who was struggling after her mother's death.
Cancer Rates Among People Living With HIV Have Declined, But More Research Still Needed
Drug Topics
SEPTEMBER 22, 2023
Disparities for patients with HIV who have cancer exist, and this is driven by social and structural determinants of health, as well as HIV stigma and lack of training for oncologists.
Norovirus Vaccine Candidate Shows Positive Results in Phase 2 Trial
Drug Topics
SEPTEMBER 8, 2023
Vaxart’s VP1-based bivalent oral tablet vaccine was developed to target the norovirus GI.1 Norwalk and GII.4 Sydney strains, which are the predominant strains affecting humans.
COVID-19 Pandemic May Have Led to a Reduction in Skin Cancer Screening Access
Drug Topics
SEPTEMBER 12, 2023
A study indicates that possible disruptions in skin cancer screenings and general dermatologic care at the time of the pandemic could have resulted in fewer diagnoses of melanoma generally.
HHS Recommends Cannabis Move From Schedule 1 to Schedule 3, the Result Will Impact Opportunities for Drug Research
Pharmacy Times
SEPTEMBER 19, 2023
Moving cannabis to Schedule 3 will make it easier to research, resulting in the development and creation of new cannabinoid-based pharmaceuticals, with notable potential in oncology.
Increased Vitamin D Intake Can Decrease Symptoms of Depression, Anxiety
Pharmacy Times
SEPTEMBER 8, 2023
Although findings indicate a relationship between vitamin D and mood disorders, further research is needed to clarify efficacy of specific vitamin D levels, as well as supplement dose and form.
Study Shows Not All IVIG Products Are Created Equal in Alzheimer Disease
Pharmacy Times
SEPTEMBER 12, 2023
One IVIG product showed overall improvement in neuroprotection, including alleviating cognitive decline and ameliorating AB deposition in Alzheimer disease.
Independent Rx Forum - Charting the Course of Community Pharmacies
Pharmacy Times
SEPTEMBER 26, 2023
Tune in to this episode of the Independent Rx Forum to gain a comprehensive understanding of the enduring significance of independent and community pharmacies.
FDA Approves Empagliflozin for Adults With Chronic Kidney Disease at Risk of Progression
Pharmacy Times
SEPTEMBER 22, 2023
Empagliflozin (Jardiance) demonstrated a 28% relative risk reduction, with an absolute risk reduction of 3.6% per patient-year at risk in the treatment of chronic kidney disease.
Ensuring Health Equity in Vaccination Access: How Pharmacies Can Work With Community Organizations
Pharmacy Times
SEPTEMBER 15, 2023
Community pharmacies and organizations can collaborate to tailor strategies and interventions and address the challenges and specific needs of the community.
Let's personalize your content